2.31
-0.19 (-7.6%)
-0.19 (-7.6%)
Upgrade to Real-Time
Regular Market
Low
2.15
High
5.84
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.19 | -7.6% | 2.31 | 13:40:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.48 | 2.30 | 2.49 | 2.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.30 | 2.32 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 479 | 101,985 | $ 2.36 | $ 240,656 | - | 2.15 - 5.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:41:12 | 5 | $ 2.3153 | USD |
Period:
Draw Mode:
Acer Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 33.06M | 14.31M | 9.44M | $ - | $ - | -2.06 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 223.57k | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.48 | 2.65 | 2.28 | 2.44 | 150,674 | -0.17 | -6.85% |
| 1 Month | 2.98 | 3.07 | 2.28 | 2.56 | 83,363 | -0.67 | -22.48% |
| 3 Months | 2.93 | 3.14 | 2.28 | 2.77 | 84,816 | -0.62 | -21.16% |
| 6 Months | 4.40 | 5.39 | 2.28 | 3.73 | 460,278 | -2.09 | -47.5% |
| 1 Year | 3.65 | 5.84 | 2.15 | 3.68 | 515,014 | -1.34 | -36.71% |
| 3 Years | 20.18 | 34.10 | 1.08 | 4.78 | 246,408 | -17.87 | -88.55% |
| 5 Years | 8.55 | 34.10 | 1.08 | 5.10 | 197,627 | -6.24 | -72.98% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
